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Available online 21 November 2015AbstractObjectives: Bone loss after bariatric surgery is well recognized but the best method for quantifying bone mineral density (BMD) remains
controversial. BMD measured with dual energy X-ray absorptiometry (DXA) is prone to measurement errors in this population while quan-
titative computed tomography (QCT) is less affected. We report the skeletal changes after bariatric surgery at 1-year in a multi-ethnic Asian
cohort using both central DXA and QCT.
Methods: Areal BMD (aBMD) and volumetric BMD (vBMD) of twenty-two participants (mean age 40.6; female 59%) undergoing sleeve
gastrectomy (n ¼ 12) or gastric bypass (n ¼ 10) were measured with central DXA and QCT respectively before and 12-months after surgery.
Results: Weight and BMI decreased significantly but discordant QCT and DXA results were noted. aBMD was significantly reduced at the total
hip (TH) and femoral neck (FN) by 6.9 and 8.5% respectively but was not significantly different at the lumbar spine (LS). By contrast, there were
no significant changes in vBMD at TH and FN. Instead, a significant 11.2% decrease in vBMD was noted at the LS. These findings were largely
similar between the two surgical subgroups. Interestingly, cortical vBMD increased at both TH and FN while trabecular vBMD decreased at the
TH. These changes were observed despite no significant post-operative changes in serum calcium, iPTH or 25-OH vitamin D levels.
Conclusion: Technical or physiological factors may be involved in the discordance between QCT and DXA results during short-term follow-up
and the most suitable method of bone density measurement for post-bariatric surgery patients remains uncertain.
© 2015 The Korean Society of Osteoporosis. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Obesity is a serious public health issue in Singapore with a
rising prevalence from 6.4% in 2006 to 10.8% in 2010 [1],
mirroring the world-wide trend [2]. Obesity is difficult to treat
and current lifestyle interventions have limited efficacy [3].
Bariatric surgery is the most effective treatment for morbid
obesity and more patients are undergoing bariatric surgery [4].
In addition to sustained long-term weight loss, bariatric sur-
gery leads to dramatic improvement in a wide range of
obesity-related conditions including type 2 diabetes mellitusElsevier B.V. This is an open access article under the CC BY-NC-ND license
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Despite the improvement in metabolic health, a number of
studies have consistently reported significant bone loss after
surgery [10] and the concern of a greater fracture risk is
supported by a recent population-based study that reported a
2.3 fold increase in fracture risk among patients who under-
went bariatric surgery [11]. An accurate measurement of bone
mass and bone mineral density is therefore required for
optimal assessment and management of bone health.
At present, guidelines recommend the periodic measure-
ment of BMD using dual-energy X-ray absorptiometry (DXA)
after bariatric surgery [12,13]. However, the accuracy of DXA
is affected by excess adiposity and changes in body tissue
distribution during rapid weight loss [14e16]. Quantitative
computed tomography (QCT) by contrast, is thought to be less
affected [17] and may also aid with the estimation of trabec-
ular and cortical bone changes. The majority of studies to date
were performed using DXA except one study that used QCT
for the evaluation of axial BMD in 30 patients who underwent
Roux-en-Y gastric bypass (RYGB). This was the first study
that used central QCT and central DXA in a gastric bypass
population and they had reported discordant measurements
between the two techniques at 12-months [18]. Studies that
had used peripheral QCT in bariatric surgery patients reported
different findings, with one study highlighting cortical bone
loss [19] and another study highlighting preservation of
volumetric density and bone strength [20]. These studies
highlighted the technical difficulties in obtaining an accurate
assessment of bone density in the bariatric surgery population
and thus the most appropriate bone imaging modality for this
subgroup remains debatable. It was also unclear whether dif-
ferences between DXA and QCT would be observed in a
different ethnic population and using other types of bariatric
surgery techniques.
In this study, we aim to study the skeletal effects of bar-
iatric surgery in a group of multi-ethnic Asian population
using both central DXA and central QCT.
2. Methods2.1. SubjectsTwenty-two participants (mean age 40.6; range 25.6e56.8
years) with BMI 37.5 or 32.5 kg/m2 with obesity-related
co-morbidities were recruited from the Singapore General
Hospital's Obesity Metabolic Unit. Sleeve gastrectomy (SG)
[21] or gastric bypass (GB) [22,23] was performed using
laparoscopic techniques by two surgeons. The selection of
bariatric surgery techniques was based on clinical criteria.
Exclusions were weight >150 kg, thyroid dysfunction, active
malignancy, significant cardiac or renal dysfunction, prior
bariatric or complex abdominal surgeries and usage of medi-
cations that could alter bone metabolism (e.g. bisphospho-
nates, parathyroid hormones, estrogen, activated vitamin D
and glucocorticoids). Nutritional guidelines by the American
Association of Clinical Endocrinologist, The Obesity Society,
and American Society for Metabolic & Bariatric Surgery [12]and American Endocrine Society [13], were adapted to our
local practice to actively correct vitamin D deficiency before
surgery and to supplement calcium and vitamin D after sur-
gery. Individuals with vitamin D deficiencies were treated with
oral ergocalciferol (vitamin D2) 50,000 IU three times per
week for two weeks before surgery and participants received
supplements with oral elemental calcium 1000 mg/day and
ergocalciferol 50,000 IU per week after surgery. Institutional
Review Board approval and written informed consents were
obtained before the start of the study.2.2. Hormone and substrate measurementsBlood samples were obtained from study participants after an
overnight fast of 8 hours. To avoid analytical variation, serum
and plasma were stored at 80 C and analyzed in batch after
completion of the 1-year follow-up. Serum total 25-hydroxy
vitamin D (25-OH Vit D) was measured using carbon-
ylmetalloimmunoassay (Abbott Diagnostics, Wiesbaden, Ger-
many) and intact parathyroid hormone level (iPTH) using
electrochemiluminescence immunoassay (Roche Diagnostics,
Indianapolis, IN, USA). Serum Type I collagen C-telopeptides
(CTX) fragments was measured using enzyme linked immuno-
sorbent assay (Immunodiagnostic Systems, Boldon, United
Kingdom), while sclerostin, osteocalcin, osteopontin and osteo-
protegrin were measured using the Milliplex bone metabolism
assay (HBNMAG-51K, Millipore, St. Charles, MO, USA).2.3. Bone mineral densityAreal bone mineral density (aBMD, g/cm2) at the lumbar
spine (L1-L4), total hip (TH), left femoral neck (FN) and
whole body were measured using DXA (Hologic Discovery
Wi densitometer, Hologic, Inc, Massachussets, USA). QCT
measurements of volumetric bone mineral density (vBMD,
mg/cm3) were obtained at the lumbar spine (L1-L2) and
proximal femur (General Electric VCT LightSpeed 64 Slice
CT, General Electric Healthcare, Waukesha, WI, USA). Three-
dimensional images were reconstructed and analyzed with
QCTPro software (Mindaways Software, Inc., Austin, TX,
USA).2.4. Statistical analysisThe data was examined for normality of distribution. To
examine the post-surgical changes, paired t-test and the Wil-
coxon matched-pairs signed rank test were used for normally
and non-normally distributed continuous variables respec-
tively and Chi square test or the Fisher's exact test were used
for categorical variables. Comparisons between surgical sub-
groups were made using unpaired t-test. All analyses were
performed using SPSS version 22 (SPSS Inc., Chicago, IL,
USA). Data are represented as mean ± standard deviation or as
percentage as appropriate. A two-tailed p value  0.05 was
considered statistically significant. Study data were collected
and managed using REDCap electronic data capture tools
hosted at the Singapore General Hospital.
Table 2
DXA Measured aBMD before and after bariatric surgery.
All SG GB p#
Total aBMD, g/cm2
Baseline 1.24 ± 0.10 1.23 ± 0.09 1.27 ± 0.10 0.83
12-month 1.23 ± 0.11 1.22 ± 0.11 1.25 ± 0.10 0.74
Difference 0.01 ± 0.03 0.01 ± 0.03 0.02 ± 0.03
p* 0.10 0.69 0.04
LS aBMD, g/cm2
Baseline 1.12 ± 0.10 1.11 ± 0.11 1.13 ± 0.10 0.25
12-month 1.12 ± 0.11 1.10 ± 0.12 1.13 ± 0.11 0.50
Difference 0.00 ± 0.06 0.01 ± 0.05 0.00 ± 0.07
p* 0.85 0.63 0.89
TH aBMD, g/cm2
Baseline 1.06 ± 0.12 1.05 ± 0.12 1.08 ± 0.12 0.65
12-month 0.99 ± 0.14 0.97 ± 0.15 1.02 ± 0.12 0.40
Difference 0.07 ± 0.06 0.08 ± 0.08 0.06 ± 0.03
p* <0.01 <0.01 <0.01
FN aBMD, g/cm2
Baseline 0.98 ± 0.11 0.98 ± 0.10 0.99 ± 0.12 0.83
12-month 0.90 ± 0.12 0.88 ± 0.14 0.92 ± 0.11 0.52
Difference 0.08 ± 0.06 0.10 ± 0.08 0.07 ± 0.04
p* <0.01 <0.01 <0.01
p* represent paired differences within group before and after surgery. p#
represent differences between surgical groups (SG vs. GB). SG: sleeve gas-
trectomy, GB: gastric bypass, LS: lumbar spine, TH: total hip, FN: femoral
neck, aBMD: areal bone mineral density.
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22 patients (59% female) with a mean age of 41 ± 9.6 years
completed the study with an average follow-up of
13.3 ± 1.5 months. None of the women were menopausal. The
baseline characteristics of study participants are summarized
in Table 1. 12 patients had SG and 10 patients GB. The type of
bariatric surgery was selected based on clinical criteria. The
patients in GB group were older with a greater proportion of
chronic comorbidities including hypertension, diabetes and
hyperlipidemia ( p < 0.05) but there was no statistical differ-
ence in their pre-operative weight or BMI compared to the SG
group.
Following surgery, weight and BMI decreased by an
average of 23.8% and 9.2 kg/m2 respectively in the entire
cohort and there was no difference in post-operative weight
and BMI between the SG and GB subgroups (Table 1). In the
entire cohort, DXA measured aBMD of whole body and
lumbar spine (LS) were largely preserved following surgery
while aBMD at TH and FN decreased significantly by 6.9%
and 8.5% respectively (Table 2 & Fig. 1). Except for a small
but statistically significant decrease in total aBMD in the GB
subgroup, the post-operative changes in aBMD were largely
similar between the two surgical subgroups. Compared to
DXA-measured aBMD, QCT-measured vBMD showed a sig-
nificant 11.2% decrease at the LS but no significant changes at
TH or FN. These findings were similar between surgical
subgroups (Table 3 and Fig. 1). It was also observed that
cortical vBMD increased at both TH and FN while trabecular
vBMD decreased at the TH and did not change at the FN
(Fig. 2). No correlations between weight loss with changes in
aBMD or vBMD were noted.
Pre-operative mean 25-OH Vit D levels increased from
17.2 ± 6.6 ng/mL to 23.1 ± 7.8 ng/mL (p ¼ 0.003) following
vitamin D repletion. No significant differences in the serum
calcium, iPTH, or 25-OH Vit D levels were detected at the 12-
month follow-up compared to the post-vitamin D repleted
baseline (Table 4). Serum CTX, and osteocalcin rose signifi-
cantly 12-months after bariatric surgery. No statistically sig-
nificant changes were observed in serum Dickkopf-1,
osteopontin, osteoprotegerin and sclerostin levels at 12 months
(Table 4).Table 1
Characteristics of study participants.
All SG (n ¼ 12) GB (n ¼ 10) p
Age 40.6 ± 9.6 36.3 ± 8.0 45.6 ± 9.1 0.018
Female (%) 59.1 66.7 50
Race (%)
Chinese 45.6 50 40 0.988
Malay 27.3 25 30
Indian 27.3 25 30
Follow-up (Months) 13.3 13.8 12.7 0.085
Baseline Weight (kg) 106.3 ± 16.4 107.1 ± 14.2 105.3 ± 19.5 0.803
Post-operative Weight (kg) 80.9 ± 11.3* 80.1 ± 10.7* 81.8 ± 12.4* 0.736
Baseline BMI (kg/m2) 38.8 ± 5.9 40.5 ± 6.6 36.7 ± 4.4 0.143
Post-operative BMI (kg/m2) 29.6 ± 4.8* 30.5 ± 6* 28.6 ± 0 2.8* 0.387
*p < 0.05 vs. baseline. SG: sleeve gastrectomy, GB: gastric bypass.4. Discussion
We studied the skeletal effects of bariatric surgery in a
group of multi-ethnic Asian population using both central
DXA and central QCT and found discordant results at 1 year.
aBMD showed no change at LS but a significant decrease in
TH and FN while vBMD showed a significant decrease at LS
but no change at the TH or FN. Interestingly, cortical
component of vBMD at the TH and FN sites showed an in-
crease after bariatric surgery. Increase in osteocalcin and CTX
post-bariatric surgery was observed despite no changes in
serum calcium, iPTH and 25-OH Vit D. We demonstrated that
at the same magnitude of weight loss, the effect of bariatricLS TH FN
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Fig. 1. Post-operative changes in DXA and QCT measured BMD at different
sites. Black columns represent measurements with DXA and white columns
measurements of QCT. LS: lumbar spine, TH: total hip, FN: femoral neck,
BMD: bone mineral density.
Table 3
QCT measured vBMD before and after bariatric surgery.
All SG GB p#
LS vBMD, mg/cm3
Baseline 184 ± 36 183 ± 39 184 ± 34 0.83
12-month 162 ± 28 161 ± 31 164 ± 24 0.28
Difference 22 ± 17 23 ± 17 20 ± 18
p* <0.01 <0.01 <0.01
TH vBMD, mg/cm3
Baseline 351 ± 40 353 ± 42 350 ± 40 0.72
12-month 345 ± 66 341 ± 60 350 ± 75 0.39
Difference 6 ± 43 12 ± 39 0 ± 50
p* 0.49 0.30 0.98
NOF vBMD, mg/cm3
Baseline 347 ± 34 343 ± 32 352 ± 37 0.76
12-month 352 ± 42 347 ± 41 358 ± 44 0.76
Difference 5 ± 23 4 ± 25 6 ± 22
p* 0.35 0.60 0.44
p* represent paired differences between group before and after surgery. p#
represent differences between SG vs. GB. SG: sleeve gastrectomy, GB: gastric
bypass, LS: lumbar spine, TH: total hip, FN: femoral neck, vBMD: volumetric
bone mineral density.
Table 4
Bone markers before and after bariatric surgery.
Baseline Post-operation p value
Bone indices
Calcium (2.1e2.6 mmol/L) 2.39 ± 0.12 2.59 ± 1.10 0.422
iPTH (1.6e6.9 pmol/L) 3.28 ± 1.39 5.07 ± 6.15 0.184
25-OH Vitamin D (ng/mL) 23.1 ± 7.8 25.9 ± 6.0 0.059
CTX (ng/ml) 0.28 ± 0.13 0.66 ± 0.34 <0.001
Dickkopf-1 (pg/ml) 1021.5 ± 565.7 1032.4 ± 611.8 0.945
Osteocalcin (pg/ml) 2989.5 ± 2169 4734.1 ± 3073 0.02
Osteoprotegerin (pg/ml) 154.7 ± 60.8 184.4 ± 92.3 0.11
Osteopontin (pg/ml) 6649.7 ± 4617.8 7990.2 ± 5790.1 0.126
Sclerostin (pg/ml) 3415.6 ± 3796.2 2829.9 ± 3764.1 0.193
CTX: c-terminal telopeptide, Dickkopf-1: DKK-1, intact parathyroid
hormone: iPTH, 25-hydroxy Vitamin D: 25-OH vitamin D.
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underwent malabsorptive procedure (GB) vs. those who un-
derwent restrictive procedure (SG).
Bone loss following bariatric surgery is well recognized
and a multitude of factors such as mechanical offloading from
weight loss, mineral malabsorption, secondary hyperparathy-
roidism and changes in gut-derived hormones and adipokines
are thought to be involved [10,24]. A decrease in bone mass,
as a physiologic adaptation to skeletal offloading, is to be
expected and we did observe a significant decrease in aBMD
at weight bearing sites (TH and FN) but not at LS. These
findings are consistent with those reported in the literature
[25e28]. The lack of change in aBMD at LS could be partially
explained by the smaller degree of post-operative weight loss
compared to most other studies (23.8% vs. 30e40%) [25e28].
However, a significant decrease in vBMD was detected at LS
with QCT. These discordant results could be partially
explained by the technical differences between the twoTH FN-5
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Fig. 2. Post-operative changes in QCT measured trabecular or cortical BMD at
the hip and neck of femur. Black columns represent measurements of cortical
and white columns measurements at trabecular BMD. TH: total hip,
FN: femoral neck, BMD: bone mineral density.imaging techniques. DXA provides a 2-dimensional assess-
ment of bone and cannot distinguish between the overlying fat
and lean tissues. It therefore makes certain assumptions about
bone size and its surrounding soft tissue composition [16].
These assumptions do not hold true in the extremes of body
weight and during profound weight loss where marked
changes in body composition and fat distribution will occur
[15] and measurement errors as large as 20% have been re-
ported [14]. QCT by contrast, measures vBMD regardless of
bone size and it can distinguish compartments of body
composition with 3D imaging acquisition and analysis.
Human simulation experiments have found QCT measurement
of vBMD at LS to be less affected by changes in overlying
subcutaneous fat compared to aBMD DXA measurements
[17].
Our observation of a more than two fold increase in serum
osteocalcin and in serum CTX implied significant changes in
bone metabolism post bariatric surgery. However, in contrast
to a recent study, sclerostin levels did not change [29] and this
may be related to our approach to actively correct vitamin D
deficiency [30]. Several prospective studies have showed that
changes in bone turnover occur as early as 3-months following
bariatric surgery [28] even when calcium-PTH-vitamin D axis
appeared to be undisturbed [18]. Using peripheral QCT, Stein
et al. proposed that bone loss after bariatric surgery could be
caused by secondary hyperparathyroidism [19]. Avoidance of
secondary hyperparathyroidism in our population may
partially explain the cortical vBMD results. We also postulate
that reduction in visceral adiposity may contribute based on an
observation that visceral adiposity was negatively associated
with femoral neck cortical vBMD in young men [31].
Similar changes in DXA measured aBMD have been re-
ported in individuals undergoing GB and SG by others in-
vestigators [32]. However, only one other study had evaluated
changes in axial BMD using central QCT and this was limited
to GB procedures [18]. We extend the findings of these earlier
trials [18,32] by including longitudinal data from a multi-
ethnic Asian cohort. Asians are known to have a distinct
metabolic phenotype with higher body fat percentage and
adverse cardio-metabolic risk profile at a lower BMI [33,34]
and the skeletal response to bariatric surgery is not known.
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undergoing bariatric surgery is whether post-surgical skeletal
changes will lead to a higher fracture risk. Two epidemio-
logical studies have examined post-bariatric surgery fracture
risk and reported mixed results. An earlier retrospective
study reports no increase in the fracture rates of 2079 bar-
iatric surgery patients compared to BMI matched controls
over an average period of 2.2 years although a trend towards
an increased fracture risk with greater weight loss was
observed [35]. More recently, prospective study on a smaller
group of 258 patient but followed-up for a longer duration
(mean 9 years) reported a higher relative risk of 2.3-fold
[11]. Given that fractures are the most important clinical
consequence of bone loss, the selection of any imaging
modality should be the one that correlates best with future
fractures.
There are several limitations in our study. Firstly, our study
population is small. The inclusion of a prospectively followed-
up control group would be useful in mitigating measurement
drifts. Secondly, findings beyond our study period of one year
will provide additional information on the long-term skeletal
health. Recent two-year data from the earlier central QCT
study in Boston showed a rapid decrease in TH vBMD after
the first year [36] and could reflect the temporal effect of
continual trabecular bone loss and deterioration in skeletal
microarchitecture. Finally, we reported the post-surgical
changes in patients who underwent SG and GB and any
comparisons between these different bariatric surgery tech-
niques need to be interpreted in the non-randomized nature of
the study design. However, the weight and metabolic effects
between these two techniques seem to be comparable in ran-
domized studies [37] and the intention of this study is to report
observations in changes in bone density in a setting that most
closely approximates “real-world” practice, including clinical
decision for the choice of surgery.
Bariatric surgery is the most effective treatment for patients
with morbid obesity but its effects on bone metabolism and
fracture risk remain uncertain. Future studies using multi-
modality assessments and over longer duration are needed to
clarify the most appropriate imaging methods for assessing of
skeletal changes after bariatric surgery.
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